Semaglutide is a GLP-1 receptor medication that may help support appetite control, portion management, satiety, and long-term weight reduction alongside lifestyle changes and provider guidance
Use of these medications on the index date was also an exclusion criterion, with the exception of treatment initiation with semaglutide or DPP4i on the index date in the corresponding study groups
For patients ready to explore personalized maintenance dosing strategies, Ivms GLP-1 ID program offers the individualized care, ongoing medical support, and comprehensive tools needed to navigate this phase successfully
For specific guidance, speak with your physician
While these injections can help you to eat less calories, the use of peptides can help to improve your metabolism and help to maintain very important muscle mass
Such an easy process to complete